Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Sunitinib-related cardiotoxicity: an interdisciplinary issue

Nature Clinical Practice Cardiovascular Medicine volume 5, pages 364–365 (2008)Cite this article

boxed-textChu TF et al. (2007) Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 370: 2011–2019

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ewer MS et al. (2005) Reversibility of trastuzumab–related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol 23: 7820–7826

    Article  CAS  Google Scholar 

  2. Kerkela R et al. (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12: 908–916

    Article  Google Scholar 

  3. Yeh ET et al. (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109: 3122–3131

    Article  Google Scholar 

  4. Khakoo AY et al. (2008) Heart failure associated with sunitinib malate, a multi-targeted receptor tyrosine kinase inhibitor. Cancer [10.1002/cncr.23460]

  5. Ewer MS and Lenihan DJ (2008) Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground? J Clin Oncol 26: 1201–1203

    Article  Google Scholar 

  6. Chien KR (2006) Herceptin and the heart—a molecular modifier of cardiac failure. N Engl J Med 354: 789–790

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. MS Ewer is Professor of Medicine and Special Assistant to the Vice President, at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Michael S Ewer

  2. DJ Lenihan is Associate Professor of Medicine and Director of Clinical Research, at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Daniel J Lenihan

  3. AY Khakoo is Assistant Professor of Medicine, at the University of Texas MD Anderson Cancer Center, Houston, TX, USA.,

    Aarif Y Khakoo

Authors
  1. Michael S Ewer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J Lenihan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aarif Y Khakoo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael S Ewer.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ewer, M., Lenihan, D. & Khakoo, A. Sunitinib-related cardiotoxicity: an interdisciplinary issue. Nat Rev Cardiol 5, 364–365 (2008). https://doi.org/10.1038/ncpcardio1222

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1222

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing